British patients trial major new blood test for Alzheimer’s disease
New blood test could revolutionise Alzheimer’s diagnosis in UK
- British patients are trialling a major new blood test for Alzheimer’s disease, which could revolutionise the diagnosis of the condition.
- The trial, led by a University College London team, investigates whether measuring the p-tau217 protein can improve early and accurate diagnosis within the NHS.
- This blood test is considered as accurate as current, more invasive methods like PET scans and lumbar punctures, but is significantly more accessible and cheaper.
- The study will recruit 1,100 people from memory clinics across the UK to assess the test's effectiveness in guiding diagnosis and treatment, and its impact on patients.
- Experts anticipate answers within three years, with the potential for the test to be integrated into NHS practice, enabling earlier diagnosis crucial for accessing current and future therapies.
Bookmark popover
Removed from bookmarks